Goldman Sachs Initiates Coverage On Cloudflare with Sell Rating, Announces Price Target of $51
Goldman Sachs analyst Gabriela Borges initiates coverage on Cloudflare (NYSE:NET) with a Sell rating and announces Price Target of $51.
Goldman Sachs Initiates Coverage On SentinelOne with Neutral Rating, Announces Price Target of $17
Goldman Sachs analyst Gabriela Borges initiates coverage on SentinelOne (NYSE:S) with a Neutral rating and announces Price Target of $17.
Goldman Sachs Initiates Coverage On Fortinet with Buy Rating, Announces Price Target of $73
Goldman Sachs analyst Gabriela Borges initiates coverage on Fortinet (NASDAQ:FTNT) with a Buy rating and announces Price Target of $73.
Goldman Sachs Initiates Coverage On CrowdStrike Holdings with Buy Rating, Announces Price Target of $141
Goldman Sachs analyst Gabriela Borges initiates coverage on CrowdStrike Holdings (NASDAQ:CRWD) with a Buy rating and announces Price Target of $141.
Loop Capital Initiates Coverage On Core & Main with Buy Rating, Announces Price Target of $28
Loop Capital analyst Jeffrey Stevenson initiates coverage on Core & Main (NYSE:CNM) with a Buy rating and announces Price Target of $28.
B of A Securities Initiates Coverage On Okta with Underperform Rating, Announces Price Target of $64
B of A Securities analyst Madeline Brooks initiates coverage on Okta (NASDAQ:OKTA) with a Underperform rating and announces Price Target of $64.
JP Morgan Reinstates Overweight on Walt Disney, Maintains $135 Price Target
JP Morgan analyst Philip Cusick reinstates Walt Disney (NYSE:DIS) with a Overweight and maintains $135 price target.
Citigroup Initiates Coverage On 9 Meters Biopharma with Neutral Rating, Announces Price Target of $2.7
Citigroup analyst Samantha Semenkow initiates coverage on 9 Meters Biopharma (NASDAQ:NMTR) with a Neutral rating and announces Price Target of $2.7.
MoffettNathanson Initiates Coverage On HashiCorp with Outperform Rating, Announces Price Target of $43
MoffettNathanson analyst Sterling Auty initiates coverage on HashiCorp (NASDAQ:HCP) with a Outperform rating and announces Price Target of $43.
Ascendiant Capital Initiates Coverage On BioSig Technologies with Buy Rating, Announces Price Target of $5
Ascendiant Capital analyst Edward Woo initiates coverage on BioSig Technologies (NASDAQ:BSGM) with a Buy rating and announces Price Target of $5.